Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Suppression of transcription factor early growth response 1 reduces herpes simplex virus lethality in mice
Shih-Heng Chen, Hui-Wen Yao, I-Te Chen, Biehuoy Shieh, Ching Li, Shun-Hua Chen
Shih-Heng Chen, Hui-Wen Yao, I-Te Chen, Biehuoy Shieh, Ching Li, Shun-Hua Chen
View: Text | PDF
Research Article Virology

Suppression of transcription factor early growth response 1 reduces herpes simplex virus lethality in mice

  • Text
  • PDF
Abstract

Herpes simplex virus type 1 (HSV-1) infection is the most common cause of sporadic, fatal encephalitis, but current understanding of how the virus interacts with cellular factors to regulate disease progression is limited. Here, we show that HSV-1 infection induced the expression of the cellular transcription factor early growth response 1 (Egr-1) in a human neuronal cell line. Egr-1 increased viral replication by activating promoters of viral productive cycle genes through binding to its corresponding sequences in the viral promoters. Mouse studies confirmed that Egr-1 expression was enhanced in HSV-1–infected brains and that Egr-1 functions to promote viral replication in embryonic fibroblasts. Furthermore, Egr-1 deficiency or knockdown of Egr-1 by a DNA-based enzyme greatly reduced the mortality of HSV-1–infected mice by decreasing viral loads in tissues. This study provides what we believe is the first evidence that Egr-1 increases the mortality of HSV-1 encephalitis by enhancing viral replication. Moreover, blocking this cellular machinery exploited by the virus could prevent host mortality.

Authors

Shih-Heng Chen, Hui-Wen Yao, I-Te Chen, Biehuoy Shieh, Ching Li, Shun-Hua Chen

×

Figure 3

Egr-1 activates HSV-1 gene promoters by binding to its corresponding sequence in the promoter.

Options: View larger image (or click on image) Download as PowerPoint
Egr-1 activates HSV-1 gene promoters by binding to its corresponding seq...
(A) The activities of the ICP27, ICP22/47, ICP4, and US6 promoters in SK-N-SH cells stably transfected with plasmids containing Egr-1 (Egr-1) or empty vector (vector). (B) The activities of the ICP27 promoter (ICP27) or ICP27 promoter with a mutated Egr-1–binding sequence (ICP27 mut) (top panel) and Western blot analysis of Egr-1 (middle panel) and α-tubulin (bottom panel) in 1 clone of SK-N-SH cells stably transfected with vector plasmid and 2 clones of SK-N-SH cells stably transfected with Egr-1 plasmid, clone numbers 4 (Egr-1 no. 4) and 11 (Egr-1 no. 11). The viral promoter activities in cells stably transfected with pCB6 were set at 100%. Data show mean ± SEM from 3 independent experiments, each done in duplicate. *P < 0.05; **P < 0.005, Student’s t test. (C) Binding of Egr-1 to its corresponding sequence in the ICP27 promoter assayed by ChIP-PCR assay. Egr-1 and DNA complex from cells mock transfected (mock) or transfected with plasmids containing the ICP27 (ICP27) or mutated ICP27 (ICP27 mut) promoter was precipitated by anti–Egr-1 antibody or control rabbit IgG. The precipitated DNA and genomic DNA (input) were subjected to PCR amplification using primers specific for both ICP27 and mutated ICP27 promoters. Data are representative of at least 2 experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts